The effect of transient ischemic attack clinical pathway.

Area of Science:

• Neurology
• Healthcare Management
• Clinical Research

Background:

• Transient ischemic attack (TIA) clinical pathways (CP) are designed to standardize care, reduce costs, and improve quality.
• The overall effectiveness of TIA CP in achieving these goals requires further evaluation.

Purpose of the Study:

• To assess the impact of TIA CP on medical care costs and resource utilization.
• To provide evidence for optimizing hospital cost structures and resource management in TIA treatment.

Main Methods:

• A nonconcurrent cohort study comparing 112 patients on TIA CP with 179 patients not on CP (NCP).
• Analysis focused on length of stay, hospital costs, cost proportions (medication vs. examination), and clinical outcomes.

Main Results:

• TIA CP significantly reduced average length of stay by 2.29 days.
• Hospital costs increased by 7.9% in the CP group, but medication cost proportion decreased by 5% while examination cost proportion increased by 8%.
• No significant difference in discharge condition was observed, but the CP group had zero 30-day recurrent TIA or cerebral infarction events compared to 4% in the NCP group.

Conclusions:

• TIA CP effectively reduces length of stay and optimizes hospital expense structure by decreasing medication costs.
• The implementation of TIA CP leads to better utilization of medical resources and improved quality of care for TIA patients.
• TIA CP demonstrates a potential benefit in reducing short-term recurrence of TIA or cerebral infarction.